// App-Quantinova.ai

: Neoadjuvant Treatment and the Prolonged Risk of Venous Thromboembolism in Resectable Pancreatic Cancer

Researchers

Presenter

  • A. Eurola

Principal Investigators

  • H. Mustonen

  • N. Mattila

  • R. LASSILA

  • C. Haglund

  • H. Seppänen

Medical Centers

  • Helsinki University Hospital, Abdominal Center, Helsinki, Finl

  • Helsinki University Hospital, Unit of Coagulation Disorders, Helsinki, Finland

  • Helsinki University Hospital, Gastrointestinal Surgery, Helsinki, Finland

Locations

  • Finland

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Venous thrombosis

  • Pancreato-biliary malignancies

  • Solid malignancies

  • Microphthalmia, syndromic, 9

Biomarkers

  • Body mass index

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved